Is The Public Engaged In Health Technology Assessment?

Published Jan 17, 2013
Queensland, Australia - Many health jurisdictions are moving towards greater public involvement in health technology assessment. Dr. Jennifer Whitty, PhD, Senior Lecturer with the Centre for Applied Health Economics and Deputy Director of the Population and Social Health Research Program at Griffith Health Institute, Griffith University explored how, why and to what extent patients and the public are engaged in health technology assessment processes and decision-making. For the exploration, Dr. Whitty undertook an international web-based survey of 39 organisations involved in health technology assessment. The survey findings suggest that two thirds of the responding organisations undertake public engagement activities such as public hearings, consultation via interactive websites, or focus groups. Mechanisms based on one-way communication or consultations were the most common; although, some organisations have used or intend to use participatory approaches such as citizens’ juries or consensus conferences. The findings suggest engagement is undertaken for a range of reasons, but a number of challenges to engagement were also identified. Dr. Whitty says “This survey provides further insight into the public engagement approaches that are used by health technology assessment organisations in practice.” The study, “An international survey of the public engagement practices of Health Technology Assessment Organisations,” is published inValue in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies

Apr 28, 2026

Value in Health announced the publication of a special themed section of research papers that advances evidence and methods for evaluating the real-world value of digital health technologies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×